Rescue therapy with adefovir in decompensated liver cirrhosis patients with lamivudine-resistant hepatitis B virus

BACKGROUND/AIMS: Adefovir dipivoxil (ADV) is a nucleotide analogue that is effective against lamivudine-resistant hepatitis B virus (HBV). The aim of this study was to determine the long-term clinical outcomes after ADV rescue therapy in decompensated patients infected with lamivudine-resistant HBV....

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Woo, Hyun Young, Choi, Jong Young, Yoon, Seung Kew, Suh, Dong Jin, Paik, Seung Woon, Han, Kwang Hyub, Um, Soon Ho, Kim, Byung Ik, Lee, Heon Ju, Cho, Mong, Lee, Chun Kyon, Kim, Dong Joon, Hwang, Jae Seok
פורמט: Artigo
שפה:Inglês
יצא לאור: The Korean Association for the Study of the Liver 2014
נושאים:
Original Article
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC4099332/
https://ncbi.nlm.nih.gov/pubmed/25032183
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3350/cmh.2014.20.2.168
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים